Search

Search Constraints

You searched for: Author/Creator Pollack, Ian

Search Results

21. MBCL-07. 5-YEAR EVENT-FREE SURVIVAL (EFS) AND NEUROCOGNITIVE OUTCOME IN CHILDREN WITH MEDULLOBLASTOMA (MB) BETWEEN 3 AND 5 YEARS OF AGE: RESULTS OF CHILDREN'S ONCOLOGY GROUP STUDY ACNS0331. Issue 2 (22nd June 2018)

22. MBCL-16. EFFICACY OF CARBOPLATIN GIVEN CONCOMITANTLY WITH RADIATION AND ISOTRETINOIN AS A PRO-APOPTOTIC AGENT IN MAINTENANCE THERAPY IN HIGH-RISK MEDULLOBLASTOMA: A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP. (4th December 2020)

25. MODL-26. CHILDREN'S BRAIN TUMOR NETWORK: ACCELERATING RESEARCH THROUGH COLLABORATION AND OPEN-SCIENCE. (4th December 2020)

26. NIMG-58. IMMUNOPET OF 89ZR-DFO-CD69 AB VISUALIZES T-CELL ACTIVATION AND PREDICTS SURVIVAL FOLLOWING IMMUNOTHERAPY IN MURINE GBM MODEL. (14th November 2022)

27. Novel and shared neoantigen for glioma T cell therapy derived from histone 3 variant H3.3 K27M mutation. (4th November 2015)

28. Novel and shared neoantigen for glioma T cell therapy derived from histone 3 variant H3.3 K27M mutation. Issue 2 (December 2015)

30. PATH-24. MOLECULAR CLASSIFICATION OF HIGH RISK INFANT EMBRYONAL BRAIN TUMORS ENROLLED IN THE ACNS0334 TRIAL: A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP. (4th December 2020)